- Home
- APLT vs SYPR Comparison
APLT vs SYPR Comparison
Compare APLT & SYPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- SYPR
- Stock Information
- Founded
- APLT 2016
- SYPR 1997
- Country
- APLT United States
- SYPR United States
- Employees
- APLT N/A
- SYPR N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- SYPR Industrial Machinery/Components
- Sector
- APLT Health Care
- SYPR Industrials
- Exchange
- APLT Nasdaq
- SYPR Nasdaq
- Market Cap
- APLT 37.5M
- SYPR 36.8M
- IPO Year
- APLT 2019
- SYPR 1994
- Fundamental
- Price
- APLT $0.40
- SYPR $1.62
- Analyst Decision
- APLT Buy
- SYPR
- Analyst Count
- APLT 7
- SYPR 0
- Target Price
- APLT $6.10
- SYPR N/A
- AVG Volume (30 Days)
- APLT 1.9M
- SYPR 14.5K
- Earning Date
- APLT 05-20-2025
- SYPR 05-23-2025
- Dividend Yield
- APLT N/A
- SYPR N/A
- EPS Growth
- APLT N/A
- SYPR N/A
- EPS
- APLT N/A
- SYPR N/A
- Revenue
- APLT $455,000.00
- SYPR $140,180,000.00
- Revenue This Year
- APLT $1,768.13
- SYPR N/A
- Revenue Next Year
- APLT $361.28
- SYPR N/A
- P/E Ratio
- APLT N/A
- SYPR N/A
- Revenue Growth
- APLT N/A
- SYPR 2.90
- 52 Week Low
- APLT $0.30
- SYPR $1.30
- 52 Week High
- APLT $10.62
- SYPR $3.72
- Technical
- Relative Strength Index (RSI)
- APLT 46.92
- SYPR 46.71
- Support Level
- APLT $0.39
- SYPR $1.58
- Resistance Level
- APLT $0.44
- SYPR $1.68
- Average True Range (ATR)
- APLT 0.04
- SYPR 0.07
- MACD
- APLT 0.01
- SYPR -0.00
- Stochastic Oscillator
- APLT 45.49
- SYPR 41.18
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About SYPR Sypris Solutions Inc.
Sypris Solutions Inc is a USA-based company engaged in providing truck components, oil and gas pipeline components, and aerospace and defense electronics. The company offers a range of manufacturing, engineering, design, and other technical services. The business activity of the firm is functioned through Sypris Technologies and Sypris Electronics segments. Sypris Technologies segment is engaged in the sales of machined, welded, and heat-treated steel components for heavy commercial vehicle and high-pressure energy pipeline applications whereas the Sypris Electronics segment is engaged in the sale of manufacturing services, technical services, and products to customers in the market for aerospace and defense electronics. Sypris derives the revenue from the Technologies segment.